Cytodyn Inc (CYDY)

[Maverick0408]

I am not arguing that CYDY management must take some responsibility for their foresight and decision making in CD12 trial. Shows lack of experience. Dr. Rahman is going to spearhead their regulatory affairs and trial design going forward. He didn't join the team until late last year. He has successfully lead over a dozen BLA with big pharma. So that issue will be taken care of!

But the larger point I am trying to make is that the science and technology is better than anything that's been tested and reported for severe to critical patients. Show me one study that presents better data than LL for critical patients? I point you to few below. With all the exceptions that FDA made for big pharmas in approving their drug and Fauci @ NIH pumping ph 1 trial of big pharma, isn't that hypocrisy?


Harish Seethamraju, M.D., Medical Director for the Mount Sinai Lung Transplantation Program, commented, “The CD12 trial results are very promising and leronlimab may be the only safe medication to help critically ill patients.”

Is he pumping the stock? I don't think so.

Dr. Patterson wrote a letter in support of CYDY last week to FDA. Why would he do that despite the differences that may have emerged with CYDY management in the last few months?

You out of all know the struggle of small biotechs. I assume you're long NWBO as I am. 13-15 yr long GBM trial? What happened there with AF and his buddies putting all kinds of non sensical legal stuff as hurdles about 6-7 years ago and the resource NWBO had to put to fight the legal cases questioning integrity, trial design, etc. In fact, he's been on recording for the past 7-8 years saying NWBO trial failed. Seems he knows more about the data than anyone else while it's not been unblinded for everyone else. And calling Linda Powers the worst CEO ever. We know NWBO emerged victorious from all those baseless allegations and is on the verge of revealing their Ph 3 data to the world. It's up 10x in the last 12 months! Ultimately science and KOL support wins! NWBO hasn't revealed the ph 3 data yet and we don't know if FDA will approve it either. But it's clear UK MHRA and EU will given the acceptance of end point changes last year and the scale up of manufacturing in the UK over the last 6 months or so!


Here are some of the publications with LL for reference:


https://academic.oup.com/cid/advance-article/doi/10.1093/cid/ciaa1583/5932277?login=true

https://www.sciencedirect.com/science/article/pii/S1201971220323055

https://www.sciencedirect.com/science/article/pii/S2589909021000034

https://www.medrxiv.org/content/10.1101/2020.05.02.20084673v1